Type Whole antibody Target HER3 CAS Number 1262787-83-6 | ATC code none ChemSpider none | |
Patritumab (INN) is a human monoclonal antibody designed for the treatment of cancer. It acts as an immunomodulator.
Clinical trials
It is in a phase 2 clinical trial for squamous cell cancer of the head and neck.
It is to be included in a new arm of the I-SPY 2 breast cancer trial.
References
Patritumab Wikipedia(Text) CC BY-SA